Muscarinic receptor subtype involvement in brain cholinergic stimulation by Intracerebroventricular neostigmine in sinoaortic denervated rats

General Pharmacology

Volumn 31, Issue 4, 1998, Pages 583-588

  Taira, Carlos Alberto ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

4 DAMP; AF DX116; Blood pressure; Heart rate; Pirenzepine; Sinoaortic denervation

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; MUSCARINIC RECEPTOR; NEOSTIGMINE; OTENZEPAD; PIRENZEPINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CHOLINERGIC STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CEREBRAL VENTRICLES; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; FEMALE; HEART RATE; MALE; MUSCARINIC ANTAGONISTS; NEOSTIGMINE; PARASYMPATHECTOMY; PIRENZEPINE; RATS; RECEPTORS, MUSCARINIC; SINUS OF VALSALVA;

EID: 0032190002     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00043-3     Document Type: Article

References (25)

1. Alexander S.P.H., Peters J.A. The 1997 Receptor Icon Channel Nomenclature Supplement. 8:1997;Elsevier, Cambridge, UK.
2. Askhenazi A., Peralta E.G. Muscarinic acetylcholine receptors. de Peroutka S.J. Handbook of Receptors and Channels, Vol 1. 1994;1-27 CRC Press, Boca Raton, FL.
3. Brezenoff H.E. Centrally induced pressor responses to intravenous and intraventricular physostigmine evoked via different pathways. Eur. J. Pharmac. 23:1973;290-292.
4. Brezenoff H.E., Giuliano R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Ann. Rev. Pharmac. Toxicol. 22:1982;341-381.
5. Brezenoff H.E., Carney K., Buccafusco J.J. Potentiation of the carotid artery occlusion reflex by a cholinergic system in the posterior hypothalamic nucleus. Life Sci. 30:1982;391-400.
6. Brezenoff H.E., El-Fakahany E.S., Xiao Y.-F. The effect of 4-DAMP mustard on blood pressure and muscarinic binding in spontaneously hypertensive rats. Ann. Neurosci. 1:1990;24-33.
7. Bruning J.L., Kintz B.L. Computational Handbook of Statistics. 2:1977;Scott Foresman Co, Glenview, IL.
8. Buccafusco J.J. The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmac. Rev. 48:1996;179-211.
9. Buchholz R.A., Hubbard J.W., Nathan M.A. Comparison of 1-hour and 24-hour blood pressure recordings in central or peripheral baroreceptor-denervated rats. Hypertension. 8:1986;1154-1163.
10. Cooper J. R., Bloom F. E. and Roth R. H. (1996) The Biochemical Basis of Neuropharmacology, 7th Ed., pp. 194-225. Oxford University Press, New York.
11. de Balbian Verster F., Robinson C.A., Hengeveld C.A., Bush E.S. Freehand cerebroventricular injection technique for unanesthetized rats. Life Sci. 10:1971;1395-1402.
12. De Groot J. The Rat Forebrain in Stereotaxic Coordinates. 1959;Amsterdam, Nord-Hollandsche Uitgevers Maatschappij.
13. Eglen R.M., Whiting R.L. Muscarinic receptor subtypes. a critique of the current classification and a proposal for a working nomenclature J. Auton. Pharmac. 5:1986;323-346.
14. Freedman S.B., Beer M.S., Harley E.A. Muscarinic M1, M2 receptor binding. Relationship with functional efficacy. Eur. J. Pharmac. 156:1988;133-142.
15. Giuliano R., Brezenoff H.E. Increased central cholinergic activity in rat models of hypertension. J. Cardiovasc. Pharmac. 10:1987;113-122.
16. Krieger E.M. Neurogenic hypertension in the rat. Circ. Res. 15:1964;511-521.
17. Martin J.R. Pressor response to posterior hypothalamic administration of carbachol is mediated by muscarinic M3 receptor. Eur. J. Pharmac. 215:1992;83-91.
18. Pazos A., Wiederhold K.H., Palacions J.M. Central pressor effects induced by muscarinic receptor agonists. evidence for a predominant role of the M2 receptor subtype Eur. J. Pharmac. 125:1986;63-70.
19. Scheucher A., Pirola C.J., Balda M.S., Dabsys S.M., Alvarez A.L., Finkielman S., Nahmod V.E. Muscarinic M1 receptors in the lateral septal area mediate cardiovascular responses to cholinergic agonists and bradykinin. supersensitivity induced by chronic treatment with atropine Neuropharmacology. 26:1987;181-185.
20. Sundaram K., Krieger A.J., Sapru H. M2 muscarinic receptors mediate pressor responses to cholinergic agonists in the ventrolateral medullary pressor area. Brain Res. 449:1988;141-149.
21. Sundaram K., Murugaian J., Watson M., Sapru H. M2 muscarinic receptor agonists produce hypotension and bradycardia when injected into the nucleus tractus solitarii. Brain Res. 477:1989;358-362.
22. Taira C.A., Enero M.A. Participation of cholinergic pathways in sinoaortic denervated rats. Gen. Pharmac. 16:1985;145-149.
23. Taira C.A., Enero M.A. Central muscarinic involvement in cardiovascular control in sinoaortic denervated rats. Eur. J. Pharmac. 159:1989;265-272.
24. Trimarchi G.R., Buccafusco J.J. Changes in regional brain synaptosomal high affinity choline uptake during the development of hypertension in spontaneously hypertensive rats. Neurochem. Res. 12:1987;247-254.
25. Xiao Y.-F., Brezenoff H.E. The role of M2 muscarinic receptors in the posterior hypothalamus in the pressure response to intracerebroventriculary-injected neostigmine. Neuropharmacology. 24:1988;1061-1065.